KOFA AI-120S CLIA Analyzer Successfully Launched at CACLP Expo

The 18th CACLP Expo was successfully held in Chongqing International Expo Center, China from Mar 28th to 30th.

After thirty years' development, CACLP Expo now is regarded as one of the largest, the most influential and professional trade show in China In Vitro Diagnostics (IVD) and clinical laboratory industry.

During the peroid of CACLP Expo, KOFA Biotech launched the new product, AI-120S automatic chemiluminescence immunoassay analyzer. Professor Kang Xixiong, Professor Zheng Junsong, and many well-known experts in the field of in-vitro-diagnostic were invited to participate in this new product launch conference. The experts and exhibition visitors were highly impressed by the excellent product performance and feature.

AI-120S CLIA analyzer is based on acridinium ester labeled direct chemiluminescence technology, with higher specificity and sensitivity. It is with the throughput up to 120 tests per hour, covering the detection of glycometabolism, fertility, cardiac markers, tumor markers, inflammation, thyroid, etc, which greatly expands and enriches the application of traditional tests. It can be used in central laboratories, emergency rooms, ICU, chest pain centers, stroke centers a, and also be used in primary medical institutions.

In the future, KOFA Biotech will continue to give full play to its own advantages, uphold the concept of science and technology benefit everyone, and constantly carry out product research and development innovation, management mode innovation, medical device innovation, to meet the future development needs, relying on its own technology and strong strength to actively carry out development and cooperation in production, study, and research.